0 items USD 0.00Search
- Did you mean
- crown%e2%80%99s%disease
Your search for "Crohn%25E2%2580%2599s%2520disease" gave back 414630 results.
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Inflammatory Bowel Disease (IBD) Treatment market size was valued at US$ 1579.4 million in 2023. With growing demand in downstream market...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021 Summary According to the recently published report '5-Hydroxytryptamine Receptor 7...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or...
Catalog:
Global Markets Direct
December 2021
Price: USD 3,500.00
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of...
Grace Market Data
November 2023
Price: USD 3,200.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H1 2018 Summary Granulocyte...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
5-aminosalicylic Acid API is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
